Paulo FALABELLA

Person

Potomac, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of mucopolysaccharidosis II with recombinant human iduron...
- Patent number 11,986,515
- Issue date May 21, 2024
- REGENXBIO Inc.
- Stephen Joseph Pakola
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20240117328
- Publication date Apr 11, 2024
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES
- Publication number 20240091380
- Publication date Mar 21, 2024
- Regenxbio Inc.
- Marie-Laure Nevoret
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20240058426
- Publication date Feb 22, 2024
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR OCULAR MANIFESTATIONS OF CLN2 DISEASE
- Publication number 20230364206
- Publication date Nov 16, 2023
- Regenxbio Inc.
- Christina Maria Ohnsman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20230088992
- Publication date Mar 23, 2023
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED...
- Publication number 20230059395
- Publication date Feb 23, 2023
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Paulo FALABELLA

Person

Patents Grantslast 30 patents

Treatment of mucopolysaccharidosis II with recombinant human iduron...

Patents Applicationslast 30 patents

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

GENE THERAPY FOR OCULAR MANIFESTATIONS OF CLN2 DISEASE

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED...